Oliver Kellenberger-Schonborn
Rohrbacher Str. 18
Heidelberg, BW 69115, Germany
Heidelberg, BW 69115, Germany
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 11 publications
Safety and efficacy of monoclonal antibody therapy in patients with chronic herpes simplex virus-2 genital infections: MATCH-2, a randomized double-blinded, parallel-group phase 2 multi-center trial.
Journal: Pharmacological research
Published: February 27, 2025
Phase I study of intratumoral administration of CV8102 in patients with advanced melanoma, squamous cell carcinoma of the skin, squamous cell carcinoma of the head and neck, or adenoid cystic carcinoma.
Journal: Journal for immunotherapy of cancer
Published: November 24, 2024
Safety and immunogenicity of a modified mRNA-lipid nanoparticle vaccine candidate against COVID-19: Results from a phase 1, dose-escalation study.
Journal: Human vaccines & immunotherapeutics
Published: October 18, 2024
A Phase I Study of the Pan-Notch Inhibitor CB-103 for Patients with Advanced Adenoid Cystic Carcinoma and Other Tumors.
Journal: Cancer research communications
Published: August 03, 2023
First-in-human, randomized, double-blind, placebo-controlled, dose escalation trial of the anti-herpes simplex virus monoclonal antibody HDIT101 in healthy volunteers.
Journal: Clinical and translational science
Published: May 16, 2022
Efficacy and safety of the CVnCoV SARS-CoV-2 mRNA vaccine candidate in ten countries in Europe and Latin America (HERALD): a randomised, observer-blinded, placebo-controlled, phase 2b/3 trial.
Journal: The Lancet. Infectious diseases
Published: August 31, 2021
Safety and immunogenicity of an mRNA-lipid nanoparticle vaccine candidate against SARS-CoV-2 : A phase 1 randomized clinical trial.
Journal: Wiener klinische Wochenschrift
Published: July 02, 2021
Proof-of-concept of a low-dose unmodified mRNA-based rabies vaccine formulated with lipid nanoparticles in human volunteers: A phase 1 trial.
Journal: Vaccine
Published: October 23, 2020
Tachykinin antagonists ameliorate surgically induced impairment of gastrointestinal motility in rats.
Journal: Fundamental & clinical pharmacology
Published: July 15, 2020
Tachykinin Antagonists Reverse Ischemia/Reperfusion Gastrointestinal Motility Impairment in Rats.
Journal: The Journal of surgical research
Published: January 29, 2020
Showing 1-11 of 11
Last Updated: 09/26/2026